These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 524094)

  • 1. [The course of diabetes and clinical findings in glucagonoma].
    Teuscher A; Studer PP; Krebs A; Berger M; Aeberhard P
    Schweiz Med Wochenschr; 1979 Sep; 109(35):1273-80. PubMed ID: 524094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagonoma: case report and literature review].
    das Neves MM; Martins Júnior EV; Gaburri AK; Chebli JM; Stávale JN; Herani Filho AK
    Arq Gastroenterol; 1996; 33(3):167-72. PubMed ID: 9201330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies on glucagonoma tissue.
    Berger M; Teuscher A; Halban P; Trimble E; Studer PP; Wollheim CB; Zimmermann-Telschow H; Muller WA
    Horm Metab Res; 1980 Apr; 12(4):144-50. PubMed ID: 6104627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant glucagonoma: an uncommon cause of new onset diabetes].
    Guerrero Vázquez R; Oliva Rodríguez R; Cuenca Cuenca JI; Sánchez Alberdi F; Navarro González E
    Endocrinol Nutr; 2011 Apr; 58(4):199-201. PubMed ID: 21334267
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical aspects of glucagon-producing islet cell tumors.
    Prinz RA; Dorsch TR; Lawrence AM
    Am J Gastroenterol; 1981 Aug; 76(2):125-31. PubMed ID: 6272569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant glucagonoma of the pancreas diagnoses through anemia and diabetes mellitus.
    Koike N; Hatori T; Imaizumi T; Harada N; Fukuda A; Takasaki K; Iwamoto Y
    J Hepatobiliary Pancreat Surg; 2003; 10(1):101-5. PubMed ID: 12918465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucagonoma syndrome. Report of a case.
    Domen RE; Shaffer MB; Finke J; Sterin WK; Hurst CB
    Arch Intern Med; 1980 Feb; 140(2):262-3. PubMed ID: 6243459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonoma syndrome: a case report.
    Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagonoma syndrome without diabetes mellitus].
    Mikkelsen CS; Mikkelsen DB; Vestergaard V; Clemmensen O; Nielsen HO; Bygum A
    Ugeskr Laeger; 2008 Nov; 170(47):3876. PubMed ID: 19014744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic glucagonoma and deep vein thrombosis].
    Guilarte López-Mañas J; Bellot García V; Fernández Pérez R; Caballero Plasencia A
    Gastroenterol Hepatol; 1998 Dec; 21(10):483-5. PubMed ID: 9927793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucagonoma: evolution and treatment].
    Carvajal C; Azabache V; Lobos P; Ibarra A
    Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.